| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |